Laser Assisted Therapies and Immunotherapies for Oncology
Assisted Laser Therapies and Immunotherapies for Oncology
The article was published in the Journal of Clinical Medicine under the special issue "The past, present and future of photodynamic therapy for cancer".
OncoThAI will attend the 17th Congress of the European Society for Photodynamic Therapy in Nice, France On March 16th and 17th 2018.
Following the success of the PhoS-Istos European project, MBD Texinov will propose a commercial solution for the treatment of actinic keratoses by PDT.
This special issue dedicated to the photodynamic therapy presents 3 studies led by the OncoThAI laboratory.
On the occasion of Véronique Fresnel's sporting achievement, Prof. Arnaud Scherpereel described the various progress made in the treatment of malignant pleural mesothelioma.
After the inclusion of 10 patients, the first step of the INDYGO study is now completed, enabling the analysis of data collected during the trial
This phase II clinical trial aims to treat actinic keratosis with photodynamic therapy.
Presentation of light emiting frabrics for the photodynamic treatment of actinic keratosis.
Save the date: Update PDT-PDD 2020 will be held in Nancy, France!
OncoThAI attended the European Photodynamic Therapy and Photodiagnosis Update conference from September 18th to 22nd 2018 in Kochel (Germany)
OncoThAI and the Photodynamic Therapy Awarded by the french Rare Diseases foundation and SATT Nord
The INDYGO clinical trial by OncoThAI described in the last issue of the Nature Journal
The INDYGO clinical trial presented during the annual EANS meeting
The French regulatory agencies (ANSM and CPP) authorize our clinical trial on the photodynamic treatment of the Paget's disease.
Evaluation of the PHOS-ISTOS® project completed, with a very favorable opinion from the European Commission
Third place for OncoThAI
The thesis project "Design of a light emitting fabric dedicated to intracavitary photodynamic therapy" received a favorable opinion from the ANRT for CIFRE funding.
OncoThAI will attend the 18th Congress of the European Society for Photodynamic Therapy in Brussels, France On March 8th and 9th 2019.
OncoThAI will attend the next International Photodynamic Association world congress in Boston and will present 14 papers introducing the most recent results of the lab.
Martha Baydoun, a postdoctoral fellow, has been selected by the call for projects Mobility to develop this research.
The thesis project "Development of a light emitting fabric for the treatment of peritoneal carcinomatosis of ovarian origin by intracavitary photodynamic therapy" received the favorable opinion of [...]
This day will be held in Lille on November 28, 2019.
The first patient with Paget's disease has been treated by the PAGETEX clinical protocol.
Pr. Nicolas Reyns will present our latest breakthroughs in the glioblastoma treatment.
Her thesis deals with the use of photodynamic therapy in dermatology.
Congratulations to Ludivine LARUE, Isabelle TOUBIA and Mathilde CHAMPEAU for their brilliant presentations of their research work.
Prof. Mortier presented this technology on Europe 1 radio
Pr. Serge Mordon was invited to join the Board of Pharmaceuticals.
OncoThAI's research work is named in the "Health Trophies" category with the FLUXMEDICARE device manufactured and marketed by the company TEXINOV
OncoThAI will be present in Seville at the next congress organized by the European Society of Photodynamic Therapy.
Prize awarded at the 19th Annual Congress of the European Society for Photodynamic Therapy, 28-29 February, Seville, Spain
The revolution of immuno-oncology therapy: review of immune checkpoint inhibitors efficacy & specificities for the physicians
The ISEV2020 meeting is a virtual event to be held from 20 to 22 July.
The article entitled "A facile fabrication of dissolving microneedles containing 5-aminolevulinic acid" By Mathilde CHAMPEAU and al is now online. This project is performed thanks to a collaboration [...]
Hemerion Therapeutics (www.hemerion.com), is a start-up spin-off from the OncoThAI laboratory (Pr. S. Mordon). Hemerion becomes the winner of the ILab 2020 French competition. Hemerion [...]
On September 3, 2020, OncoThAI had the honor to welcome, an INSERM delegation chaired by Prof. Gilles BLOCH, Chairman and CEO of INSERM.
The meeting to set up the pilot, monocentric, descriptive, feasibility, safety and tolerance study of the BUBOLight® device "took place on September 14 at the Jeanne de Flandre Maternity Unit of the [...]
Dr. Henri AZAIS, defended on September 22 at the Faculty of Medicine of Lille, the accreditation to direct research (HDR). Much of his presentation focused on his research project at OncoThAI [...]